SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-24-038573
Filing Date
2024-05-01
Accepted
2024-05-01 17:02:03
Documents
1
Period of Report
2024-04-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 32772
  Complete submission text file 0001213900-24-038573.txt   34162
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 WOOD LANE SUFFERN NY 10901
Business Address
Schneid Yair (Reporting) CIK: 0002008233 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39114 | Film No.: 24903929